Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
2.000
-0.045 (-2.20%)
At close: Oct 9, 2026, 4:00 PM EDT
1.950
-0.050 (-2.50%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Femasys Revenue
Femasys had revenue of $331.83K in the quarter ending June 30, 2026, a decrease of -18.92%. This brings the company's revenue in the last twelve months to $2.30M, up 21.86% year-over-year. In the year 2025, Femasys had annual revenue of $2.29M with 40.77% growth. That makes Femasys the 42,077th largest company in the world by revenue and 5,707th in the United States.
Revenue (ttm)
$2.30M
Revenue Growth
+21.86%
P/S Ratio
7.28
Revenue / Employee
$42,583
Employees
54
Market Cap
16.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.29M | 664.21K | 40.77% |
| Dec 31, 2024 | 1.63M | 557.14K | 51.97% |
| Dec 31, 2023 | 1.07M | -134.25K | -11.13% |
| Dec 31, 2022 | 1.21M | 26.53K | 2.25% |
| Dec 31, 2021 | 1.18M | 141.77K | 13.66% |
| Dec 31, 2020 | 1.04M | 108.85K | 11.72% |
| Dec 31, 2019 | 929.06K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 33.90M |
| Precision Optics Corporation | 31.53M |
| Bionano Genomics | 30.18M |
| Stereotaxis | 30.07M |
| Nephros | 20.72M |
| Milestone Scientific | 9.42M |
| Lucyd | 3.41M |
FEMY News
- 2 days ago - Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo - GlobeNewsWire
- 25 days ago - Femasys announces Minnesota Women’s Care to implement FemVue - TheFly
- 25 days ago - Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women's Care - GlobeNewsWire
- 4 weeks ago - Femasys partners with CapexMD to expand patient access - TheFly
- 4 weeks ago - Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio - GlobeNewsWire
- 5 weeks ago - Femasys registers to sell 28.12M shares of common stock for holders - TheFly
- 5 weeks ago - Femasys Registration statement: Registration filing - Filings
- 6 weeks ago - Femasys announces fertility partnership with UNC Health - TheFly